Presenting his first Budget today, Britain’s Chancellor of the Exchequer Rishi Sunak announced that research and development investment will be increased by £22 billion ($28.6 billion), making it the fastest and biggest R&D ever R&D spend.
Overall, the Office for Budget Responsibility (OBR) has said that the Budget was “largest giveaway since 1992” and it will add more than £100 billion to public debt by 2024.
Mr Sunak also announced increased tax relief for companies that carry out qualifying R&D, a measure that increases the rate of the R&D expenditure credit from 12% to 13%, which is expected to affect 7,000 firms, will cost £1.2 million.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze